On the other hand, knock-out of TLR2 has yielded conflicting results in different mouse models, with the more conventional metabolic syndrome models suggesting that loss of TLR2 is protective against NASH (108–110). Here, TLR2 is linked to metabolic dysfunction-associated steatohepatitis.